title: Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy.
abstract: The development of B and T cells from hematopoietic precursors and the regulation of the functions of these immune cells are complex processes that involve highly regulated signaling pathways and transcriptional control. The signaling pathways and gene expression patterns that give rise to these developmental processes are coordinated, in part, by two opposing classes of broad-based enzymatic regulators: histone acetyltransferases (HATs) and histone deacetylases (HDACs). HATs and HDACs can modulate gene transcription by altering histone acetylation to modify chromatin structure, and by regulating the activity of non-histone substrates, including an array of immune-cell transcription factors. In addition to their role in normal B and T cells, dysregulation of HAT and HDAC activity is associated with a variety of B- and T-cell malignancies. In this review, we describe the roles of HATs and HDACs in normal B- and T-cell physiology, describe mutations and dysregulation of HATs and HDACs that are implicated lymphoma and leukemia, and discuss HAT and HDAC inhibitors that have been explored as treatment options for leukemias and lymphomas.
authors.affiliation: Department of Biology, Boston University, Boston, MA, USA.
authors.forename: Leila
authors.initials: L
authors.lastname: Haery
authors.affiliation: Department of Biology, Boston University, Boston, MA, USA.
authors.forename: Ryan C
authors.initials: RC
authors.lastname: Thompson
authors.affiliation: Department of Biology, Boston University, Boston, MA, USA.
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Gilmore
keywords: B cells; HAT; HDAC; T cells; acetylation